Literature DB >> 1954247

Lipoprotein secretion by the human hepatoma cell line Hep G2: differential rates of accumulation of apolipoprotein B and lipoprotein lipids in tissue culture media in response to albumin, glucose and oleate.

S Arrol1, M I Mackness, I Laing, P N Durrington.   

Abstract

Serum low-density lipoprotein (LDL) concentration is a major determinant of susceptibility to the development of atherosclerosis. A major component of the protein moiety of LDL and its precursor very-low-density lipoprotein is apolipoprotein B (apo B). The human hepatoma cell line, Hep G2, was used as a model for the investigation of mechanisms which control hepatic secretion of the apo B and lipid components of lipoproteins. Using a sensitive immunoradiometric assay for apo B developed in this laboratory, we showed that bovine serum albumin inhibited and glucose, and fatty acids enhanced the rate of accumulation of apo B in the culture medium of Hep G2 cells. However, these substances did not necessarily affect LDL lipids in the same way as apo B. This finding appeared to be due to Hep G2 cells expressing lipase activities which led to triacylglycerol and phospholipid hydrolysis and lipid reuptake. Reuptake of apo B also occurred, but its rate of accumulation in the culture medium suggested it was a closer reflection of its true secretory rate.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954247     DOI: 10.1016/0005-2760(91)90156-c

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Clinical, biochemical, and immunohistochemical features of necrobiotic xanthogranulomatosis.

Authors:  M Jeziorska; A Hassan; M I Mackness; D E Woolley; A B Tullo; G S Lucas; P N Durrington
Journal:  J Clin Pathol       Date:  2003-01       Impact factor: 3.411

2.  Use of cyclodextrin to deliver lipids and to modulate apolipoprotein B-100 production in HepG2 cells.

Authors:  M R Peluso; J L Dixon
Journal:  Lipids       Date:  1997-08       Impact factor: 1.646

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.